Large-cap Healthcare company Regeneron Pharmaceuticals has logged a -7.9% change today on a trading volume of 407,266. The average volume for the stock is 649,835.
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. Based in Tarrytown, United States the company has 10,715 full time employees and a market cap of $73,033,523,200.
The company is now trading -12.53% away from its average analyst target price of $776.39 per share. The 23 analysts following the stock have set target prices ranging from $575 to $1025, and on average give Regeneron Pharmaceuticals a rating of buy.
Date Reported | Revenue ($ MM) | Cost of Revenue ($ MM) | Gross Margins (%) | YoY Growth (%) |
---|---|---|---|---|
2021-12-31 | 16,072 | 2,438 | 84.83 | -2.29 |
2020-12-31 | 8,497 | 1,120 | 86.82 | -3.59 |
2019-12-31 | 7,863 | 782 | 90.05 | n/a |